Evidence map›Paper›PMID 42281865›Full record

ReviewWorld journal of transplantation2026

Not just another shot: Tailoring vaccination in the era of modern liver transplantation.

Neven Papic, Iva Kosuta, Dominik Ljubas, Nina Vrsaljko, Vibor Sesa, Viktor Domislovic, Sidra Ahsan, Anna Mrzljak

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in World journal of transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Neven PapicSchool of Medicine, University of Zagreb, Zagreb 10000, Grad, Croatia.
Iva KosutaSchool of Medicine, University of Zagreb, Zagreb 10000, Grad, Croatia.
Dominik LjubasUniversity Hospital for Infectious Diseases Zagreb, Zagreb 10000, Grad, Croatia.
Nina VrsaljkoUniversity Hospital for Infectious Diseases Zagreb, Zagreb 10000, Grad, Croatia.
Vibor SesaLiver Transplant Unit, University Hospital Centre Zagreb, Zagreb 10000, Grad, Croatia.
Viktor DomislovicLiver Transplant Unit, University Hospital Centre Zagreb, Zagreb 10000, Grad, Croatia.
Sidra AhsanHackensack Meridian Health, Hackensack Meridian Health, Neptune, NJ 07753, United States.
Anna MrzljakSchool of Medicine, University of Zagreb, Zagreb 10000, Grad, Croatia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infections remain a leading cause of morbidity and mortality in patients with cirrhosis and liver transplantation (LT). Vaccination is underutilized despite proven benefits, and responses are often blunted by cirrhosis-associated immune dysfunction and post-transplant immunosuppression. This review synthesizes current evidence and recent advances in vaccination strategies for adult LT recipients, emphasizing optimal timing, novel vaccine platforms, and precision vaccinology. We discuss emerging data on coronavirus disease 2019, respiratory syncytial virus, and new pneumococcal and hepatitis B vaccines, highlight strategies to overcome immunogenicity gaps, and address implementation barriers. A practical roadmap and clinician-focused algorithms are proposed to integrate vaccination into the continuum of LT care.

Indexed as

ImmunosuppressionLiver transplantationPrecision vaccinologyVaccinationVaccine immunogenicity

Identifiers

PMID42281865
PMCPMC13250789

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.